Reduced Expression of 14-3-3 Gamma in Uterine Leiomyoma as Identified by Proteomics
The SURMOUNT-5 trial, published in The New England Journal of Medicine , directly compared tirzepatide to semaglutide and found tirzepatide produced 47% greater relative weight loss at 72 weeks, 20.2% of body weight versus 13.7%
Red Flags to Avoid: Providers prescribing without a consultation or medical history review Claims that GLP-1s work without diet or lifestyle changes Extremely low prices that seem too good to be true (likely not legitimate medication) No licensed provider oversight or supervision Pressure to commit to long-term contracts without trial periods Pharmacies that arent properly licensed or registered Common Side Effects to Discuss with Your Provider: Nausea and vomiting (most common, usually improves over time) Diarrhea or constipation Abdominal pain Decreased appetite Fatigue Injection site reactions Serious but rare side effects requiring immediate medical attention include severe abdominal pain, vision changes, or signs of thyroid tumors
: L- ( L- 67,8%, 31,4%) , , ,